The global pharmaceutical drying equipment market size is calculated at USD 5.84 billion in 2024, grew to USD 6.26 billion in 2025, and is projected to reach around USD 11.64 billion by 2034. The market is expanding at a CAGR of 7.14% between 2025 and 2034.
The market is shifting away from conventional belt and tray dryers toward fluidized beds, spouted beds, and advanced spray systems, which offer finer control over particle morphology and moisture distribution, especially crucial for drying biologics and complex formulations.
Pharmaceutical drying equipment R&D involves optimizing drying processes for various formulations, including APIs and excipients, using methods like spray drying, freeze drying, and fluid bed drying. Key R&D steps include understanding drying mechanisms, selecting appropriate equipment, optimizing process parameters, and scaling up production
Key Players Include: GEA, ATS Corporation, Hosokawa Micron, Freund Corporation, I.M.A. Industria Macchine Automatiche, Syntegon Technology, and BUCHI Labortechnik.
The distribution of pharmaceutical drying equipment involves a multi-step process that ensures the right equipment reaches the right pharmaceutical companies. This includes selecting suitable equipment, managing the supply chain, ensuring proper installation and validation, and providing ongoing support and maintenance.
Top Companies Include: GEA Group, ATS Corporation, Hosokawa Micron Group, and I.M.A. Industria Macchine Automatiche S.p.A.
Support and services for pharmaceutical drying equipment encompass a range of activities aimed at ensuring optimal performance and longevity of the equipment. These services typically include installation, maintenance, calibration, validation, and troubleshooting.
Top Companies Include: GEA Group and ATS Corporation
In July 2025, Florent Bordet, Chief Scientific Officer at Aenova, stated that Aenova is an end-to-end CDMO that helps clients at every stage of the drug product lifecycle, from pre-creation, development, and commercial production. One of the most important factors in the success of new pharmaceutical substances. The Aenova company’s new spray drying platform in Killorglin allows us to greatly increase the variety of solutions to speed up time-to-market and assist clients in overcoming bioavailability obstacles.
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com
